GlassScriptPhysician profile
Timothy D Gutierrez
NPI 1760741359
$5,109.88
in general payments reported to CMS, 2019-2025
25 companies · $40.39 in 2025
The $40.39 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,523 · 2020: $123 · 2021: $142 · 2022: $60.83 · 2023: $52.34 · 2024: $1,169 · 2025: $40.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,000 · Food and Beverage: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,000.35 |
| Food and Beverage | $260.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,597.65 | 2019 | |
| W. L. Gore & Associates, INC. | $1,554.86 | 2019 | |
| Bard Peripheral Vascular, INC. | $1,105.27 | 2024 | Venclose Maven Catheter |
| Intuitive Surgical, INC. | $204.56 | 2019 | |
| Ethicon US, LLC | $73.44 | 2020-2021 | |
| Silk Road Medical, INC. | $61.89 | 2020-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Stryker Corporation | $46.31 | 2019 | |
| Integra Lifesciences Corporation | $44.57 | 2020-2021 | |
| Acell, INC. | $43.53 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $39.01 | 2019 | |
| Medtronic, INC. | $37.05 | 2024 | Ellipsys Vascular Access System |
| Tela Bio, INC. | $36.36 | 2020-2021 | |
| Smith+Nephew, INC. | $33.72 | 2019-2025 | Pico 7 |
| Tactile Systems Technology INC | $29.40 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $26.29 | 2024 | Farxiga |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Potrero Medical, INC. | $25.69 | 2021 | |
| Organogenesis INC. | $24.32 | 2025 | Puraply Wound Matrix |
| Inari Medical, INC. | $24.31 | 2022 | |
| Boston Scientific Corporation | $21.73 | 2022 | |
| Kls-Martin L.P. | $15.85 | 2019 | |
| Baxter Healthcare | $15.04 | 2023 | Peri-Strips Dry |
| Pacira Pharmaceuticals Incorporated | $12.78 | 2019 | |
| Mallinckrodt Enterprises LLC | $12.67 | 2019 | |
| Lifenet Health | $12.30 | 2023 | |
| Kci USA, INC. | $11.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Gutierrez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.